Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
https://www.heraldtribune.com/story/business/2020/12/24/joan-lappin-northwest-bio-perfect-stocking-stuffer/4032912001/
An excerpt from thus article states with a different style assertion, but similar supporting indications.
Long before COVID-19, the UK set up a mechanism to identify very promising drugs for unmet needs like those of patients who contract glioblastoma. NWBO was one of three such drugs given this fast-track treatment in 2014. Six years later it seems a joke, but once they submit their drug application, they are assured a very fast review. That review time has been accelerated even more this year as the UK deals with Brexit and wants very much to remain at the forefront of drug approvals. That is why it beat the U.S. to approval of the Pfizer BioNTech vaccine now in distribution here and in the UK.
While this is still not without risk, NWBO is now selling for $1.40 a share. There are just under 1 billion shares outstanding. This drug is applicable to all 15 solid tumor cancers. Think of a body part that gets cancer, and animal trials have shown it will work in all of them. This is a vaccine manufactured from your own dendritic cells so there is no toxicity to it.
Essentially , the May 7th and 12th press releases https://nwbio.com/uk-manufacturing-facility-phase-iii-trial-updates-from-northwest-biotherapeutics-otcqb-nwbo/
The next step will be an on-site inspection of the facility by MHRA. Following the inspection, a report of the inspection results and any findings needing any corrective action will be issued by MHRA. Following completion of any actions, the Company is hopeful that an initial license will be issued and production of GMP DCVax-L products in the Sawston facility may begin by around the end of Q3.
Me: The company has continually said, UK will likely be the first to approve and therefore, the launching country .
UK will be the launching pad for initial SOC therapy and approval
.0005% of shares trade on an average day . I hardly believe this rounding error of shares represents an assessment for numerical $ values of a company stock.
The people trading nwbo could care less if the entire world die. They only want a couple hundred $ for doing nothing but pushing keys to buy and sell.
Snowflakes melting
God has much to do and July may change many lives. God bless you Sojourner55 and may your path be blessed with abundance.
Thank you for finally a breath of truth , marzan
Did you ever think the company has been advised of other compelling reasons to not release the cumulative data ? Maybe people actually holding knowledge about the process and data ,have that compelling reasoning and are adhering to their professional scientific understanding to assure success and approval.
A defamation law suit should have been filed by the company and easily won, with damages equal to stock and company value harm plus penalty for such a malicious and willful act as addressed in the letter.
per ATLinsider from twitter
$NWBO: The federally-funded Patient-Centered Outcomes Research Institute (PCORI) selected #DCVax as 1 of the new & emerging health care technologies & innovations with high potential for disruption to the current standard of care (SOC). See Page 36: https://t.co/jfty5wzmDg pic.twitter.com/uU4UtiARqX
— ATLnsider (@ATLnsider) June 22, 2021
Died 2 weeks ago . What is your point posting now?
I’m continually amazed by the lack of serious money going to work. With all the known data, proven efficacy, safety and patient feed back as of last fall, the concept of waiting until TLD to buy, is beyond my understanding. Having said that, the minor amount of shares bought and sold each day, do not represent a rounding error. They are like fleas, but still disappointing from a historical point of view as I look at decades of buying into biotech and the appreciation which was encountered much earlier in the investment cycle.
Way too many little 20k to 100k share traders in and out every day, with zero serious new investors. Investors care nothing about cancer cures or effective therapies.
The total ignorance of sellers is apparent every day the market is open. Selling at these levels only confirms the lack of understanding of dcvax-L successes with lives saved or extended.
More affirmation for DCVax
It would be funny if some company in China was buying up 100 million cheap shares with BOD blessing, so they could cash in on a buyout
Well another Jaren to correct gains in value
No rational explanation for even one share to be sold today.
Brits twiddling their thumbs as they try to figure out certification meaning in between tea times.
The Flashworks technology explanation from Sept 2020 acquisition of the company.
The Flaskworks system is designed to fundamentally change the manufacturing process from artisan hand work to assembly line-like automation. As such, the Flaskworks system is designed to enable the scale-up to far greater production volumes. Technicians will oversee the automated systems (potentially multiple systems per technician) rather than making the products themselves.
https://nwbio.com/northwest-biotherapeutics-acquires-flaskworks-breakthrough-automation-technology-for-cell-therapy-products-to-enable-scale-up-of-production-volumes-and-reduction-of-production-costs/
Flashworks is the real answer
All is good , but what a shame they article author didn’t choose to write a more in comprehensive explanation of the long clinical to the current development.
Your post yesterday was well summarized . Thank you for your efforts.
Well said Doc
All that was known for that presentation, has only increased. The company has bought new manufacturing technology, hired more technical people, expanded Sawston facility and invested in new professionals for up listing.
More people are alive because of dcvax, with the scientists and doctors more positive with extended survivability from the finished clinical.
Nothing known ? wow. I’ve found numerous articles and published data about both Northwest and the dcvax clinical data.
Your thoughts are correct
I the one surviving is you, the therapy = fantastic.
yes, God is the only one to trust. Amen
The endless discussion of TLD timing continues by no one with power to change anything todo with DCVax-L
Sage advice Dr Bala
Just a normal retail buy 500k - 1m is not that much for stock priced like NWBO and cancer therapy changing dcvax.
Great points
correct
Only the most ignorant are selling
Many warrant holders are very much short term traders and never had any consideration for holding those shares long. Much like a short term loan with a high interest paid to them by shareholders through the stock price differential.
No one with even a thread of intelligence has sold NWBO stock
Good luck with getting a death sentence cancer patient joining a clinical where even if they start dying while the other comparable patients are living, not giving them whatever the patients living are being afforded. There is always a humanitarian consideration when dealing with a disease that is resulting in assured death. We try to retard death unless we’re trying to help death occur.
looks like another 250 or more traders are trying to sell the few shares they could afford